Surveillance provinciale des infections nosocomiales

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections : surveillance results 2013–2014

From April 1, 2013, to March 31, 2014, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,939,160 inpatient days. Together, these facilities reported 97 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years. The proportion of…

Monitoring report

Healthcare-Associated Infections Provincial Surveillance Program: Highlights, Discussions and Orientations 2014–2015

The Institut national de santé publique du Québec (INSPQ) [Québec’s public health institute] has been mandated by the Ministère de la Santé et des Services sociaux (MSSS) [Québec’s ministry of health and social services] to oversee the provincial surveillance of healthcare-associated (HA) infections. The Comité sur les infections nosocomiales du Québec (CINQ) [Québec healthcare-associated infections committee] and the Comité de surveillance provinciale des infections nosocomiales (SPIN) […

Monitoring report

Carbapenemases producer Gram negative bacilli infections : surveillance results 2014–2015

Carbapenemases producer Gram negative bacilli infections Surveillance results: 2014-2015

From April 1, 2014, to March 31, 2015, 67 healthcare facilities (participation rate: 75.2%) took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,225,934 patient-days (Table 1).

In total, 9 CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (…

Monitoring report

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients in Québec : surveillance results 2014–2015

From April 1st, 2014, to March 31st, 2015, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 55,640 patient-periods (Table 1). Participating units reported 156 VARBSIs in 142 patients. The proportion of patient-periods involving a fistula accounted for 43.4%. The VARBSI incidence rate was 0.09 cases per 100 patient-periods…

Monitoring report

Central Line–Associated Bloodstream Infections in Intensive Care Units in Québec surveillance results : 2014–2015

From April 1st, 2014, to March 31st, 2015, 67 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 130,776 catheter-days. Participating ICUs reported 115 CLABSIs in 112 patients. Incidence rates were 0.34 per 1,000 catheter-days in coronary ICUs, 0.52 in teaching adult ICUs, 0.76 in non-teaching adult ICUs, 2.06 in pediatric ICUs and 2.20 in neonatal ICUs. The…

Monitoring report

Hospital-Wide Healthcare-associated Bloodstream Infections : surveillance results 2014–2015

From April 1st, 2014, to March 31st, 2015, 88 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,733,772 patient-days. Participating facilities reported 3,035 BSIs in 2,832 patients. The total incidence rate was 5.3 cases per 10,000 patient-days. The incidence rate in 2014–2015 was significantly lower compared to the average rate for 2010–2014 in facilities that…

Monitoring report

Clostridium difficile–Associated Diarrhea (CDAD) : surveillance results 2014–2015

From April 1, 2014, to March 31, 2015, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,076,655 inpatient days. The participating facilities reported 3,453 cases of healthcare-associated (HA) CDAD. The incidence rate of HA CDAD was 6.8 cases per 10,000 patient days. This incidence rate was significantly lower compared to the rate of 2013–2014. The 10-day…

Monitoring report

Vancomycin-Resistant Enterococci (VRE) Infections : surveillance results 2014–2015

From April 1, 2014, to March 31, 2015, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,839,578 patient days (Table 1). In total, 87 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.18 / 10…

Monitoring report

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections : surveillance results 2014–2015

From April 1, 2014, to March 31, 2015, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,689,050 inpatient days (Table 1). Together, these facilities reported 95 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years but has stabilized……

Monitoring report

Highlights, Discussions and Orientations 2012-2013 : Healthcare-Associated Infections Provincial Surveillance Program

The ministère de la Santé et des Services sociaux (MSSS) mandated the Institut national de santé publique du Québec (INSPQ) with the provincial surveillance of healthcare-associated infections (HAI), as outlined in the 2003–2012 Programme national de santé publique (Public Health Plan), revised in 2008 as well as in the 2006–2009 and 2010–2015 versions of the Plan d’action sur la prévention et le contrôle des infections nosocomiales (Action Plan for Preventing and Controlling HAIs) aimed at…

Synthesis and summary